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Abstract
Background: The diagnosis of the progression of periodontitis presently depends on the use of clinical symptoms
(such as attachment loss) and radiographic imaging. The aim of the multicenter study described here was to
evaluate the diagnostic use of the bacterial content of subgingival plaque recovered from the deepest pockets in
assessing disease progression in chronic periodontitis patients.
Methods: This study consisted of a 24-month investigation of a total of 163 patients with chronic periodontitis
who received trimonthly follow-up care. Subgingival plaque from the deepest pockets was recovered and assessed
for bacterial content of Porphyromonas gingivalis, Prevotella intermedia, and Aggregatibacter actinomycetemcomitans
using the modified Invader PLUS assay. The corresponding serum IgG titers were measured using ELISA. Changes in
clinical parameters were evaluated over the course of 24 months. The sensitivity, specificity, and prediction values
were calculated and used to determine cutoff points for prediction of the progression of chronic periodontitis.
Results: Of the 124 individuals who completed the 24-month monitoring phase, 62 exhibited progression of
periodontitis, whereas 62 demonstrated stable disease. The P. gingivalis counts of subgingival plaque from the deepest
pockets was significantly associated with the progression of periodontitis (p < 0.001, positive predictive value = 0.708).
Conclusions: The P. gingivalis counts of subgingival plaque from the deepest pockets may be associated with the
progression of periodontitis.
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Background
Periodontitis is a chronic inflammation, which is leaded
by periodontal bacteria and host immune response [1].
Periodontitis results in loss of connective tissue and
bone support and is a major cause of tooth loss in adults
[2]. The maintenance care following the initial active
therapy phase plays an essential part in periodontal
treatment to prevent disease progression based on the
patient’s individual needs [3].
The clinical diagnosis of chronic periodontal disease
is based on visual and radiographic assessment of the
periodontal tissues and on measurements of the space
between the tooth and gum [2]. However, traditional
clinical criteria are often insufficient for determining
sites of active disease, for monitoring quantitatively the re-
sponse to therapy or for measuring the degree of suscepti-
bility to future disease progression [4]. Therefore, it is
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necessary to establish effective markers indicating peri-
odontitis progression.
The role of salivary biomarkers and periodontal patho-
gens were determined during periodontal disease progres-
sion [5]. Salivary Porphyromonas gingivalis ratio (ratio:
P. gingivalis counts/Total bacteria counts) may be po-
tential indicators for the progression of periodontitis.
Such a salivary test could be a useful diagnostic tool for
predicting periodontal disease progression [6]. And
also, our previous report suggested the P. gingivalis ratio
would be an indicator for the progression of periodontitis
[7]. Therefore, salivary periodontal pathogens were sug-
gested as useful marker of periodontitis progression.
While, several previous studies determined the subgingi-
val plaque pathogens were useful indicators of periodontal
progression. Monitoring the proportions of P. gingivalis
and Treponema denticola in subgingival plaque had the
potential to help identify sites at significant risk for
progression of periodontitis [8]. The levels of red com-
plex bacteria (P. gingivalis, Tannerella forsythia, and T.
denticola) in subgingival plaque had a strong relation-
ship with the clinical parameters [9]. Higher levels of P.
gingivalis, Prevotella intermedia and Aggregatibacter
actinomycetemcomitans in subgingival plaque appear to
be related to an increased risk of periodontitis progres-
sion [10–12]. Similarly, A. actinomycetemcomitans, P.
gingivalis, and P. intermedia may be useful as indica-
tors of periodontitis activity [13]. In addition, presence
of A. actinomycetemcomitans in subgingival plaque was
a risk marker for periodontitis progression at the full
mouth level [14, 15]. The increase in the number of P.
gingivalis, P. intermedia in subgingival plaque of ado-
lescents depends on the severity of gingivitis and ap-
pears to be a contributing factor for the shift from
gingivitis to periodontitis [16, 17]. Thus, periodontal
pathogens of subgingival plaque were valuable risk
markers for periodontitis progression.
The bacterial tests or serum IgG tests were used to
monitor periodontitis progress [5, 6, 18]. However, it
remains unclear what periodontal bacteria from subgin-
gival plaque are the most useful for estimation of peri-
odontitis progression during regular follow-ups after
initial therapy. In addition, previous reports did not test
for possible correlations between the levels of periodon-
tal bacteria in saliva and those in subgingival plaque
from the deepest pockets.
The aims of this multicenter study were two-fold. The
first goal was to evaluate subgingival bacteriological
markers among patients treated for chronic periodontitis
who exhibited or lacked subsequent disease progression
during 24 months of regular follow-ups. The second
goal was to define diagnostic values for indicating peri-
odontitis progression and stability, including compari-
son between the levels of periodontal pathogens in
subgingival plaque from the deepest pockets compared
to those in saliva.
Methods
Study design
This study was performed as a clinical research project
for diagnosis of periodontitis, as sponsored by the
Japanese Society of Periodontology. Subjects were re-
cruited in cooperation with 17 facilities (16 university
hospitals and one clinic) in Japan, and were registered
between February 2009 and February 2012. An additional
file shows this in more detail [see Additional file 1]. The
study enrolled a total of 163 follow-up patients, that is, in-
dividuals with chronic periodontitis who had completed
active treatments such as initial therapy or periodontal
surgery. Each diagnosis was based on the Guidelines of
the American Academy of Periodontology [19]. All indi-
viduals were of age ≥ 30 years, systemically healthy, pos-
sessed at least 20 teeth, and had not taken systemic
antibiotics, anti-inflammatory drugs, or immunosuppres-
sive drugs within 3 months prior to enrollment.
Clinical assessment
The follow-up patients were seen trimonthly over a 24-
month period. At each visit, the patients received treat-
ment only to remove supragingival plaque and calculus,
if detected. To identify disease progression, a full-mouth
periodontal examination, except for the third molars,
was performed every 6 months. The following clinical
parameters were recorded: plaque index (PlI), bleeding
on probing (BOP), probing pocket depth (PPD), and
clinical attachment level (CAL). PlI was recorded at 4
sites per tooth (mesial, buccal, distal, and lingual). PPD,
CAL, and BOP were recorded at 6 sites per tooth
(mesiobuccal, buccal, distobuccal, mesiolingual, lingual,
and distolingual). Patients with at least one site of CAL
loss of ≥3 mm at a given site over the 24-month study
period were considered to be exhibiting periodontitis
progression [6, 7, 20, 21]. Intra- and inter-examiner cali-
bration sessions were conducted at the beginning and
middle of the study period.
Sample collection
At baseline, samples of subgingival plaque from the
deepest pockets, saliva, and blood were collected from
each patient. Samplings were carried out according to
the following order; blood samples, saliva samples, and
subgingival plaque samples. Whole saliva was collected
from each subject by having the individual chew on a
gum base, containing neither fragrance nor flavored in-
gredients, for 5 min. The subgingival plaque was col-
lected as follows: after removal of the supragingival
plaque, samples of subgingival plaque from the deepest
pockets (except for those at the third molars) were
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obtained by consecutive insertion (at a given site) of two
sterile number-40 paper points (Zipperer Absorbent
Paper Points, VDW GmbH, Munich, Germany) into the
periodontal pocket for 10 s per point [22]. The plaque
and saliva samples were sent immediately to a medical
laboratory (BML Corporation, Tokyo, Japan) for bacterial
analysis [6, 17, 23]. Blood sampling was performed using a
commercial kit (DEMECAL Blood Test Set; Sunstar Inc,
Osaka, Japan). In brief, device-treated serum was obtained
from a 50-μL sample of whole capillary blood collected
from the middle fingertip. The samples of sera were sent
immediately to a commercial laboratory (Leisure Inc.,
Tokyo, Japan) for immune analysis [7, 24–27].
Quantification of periodontal bacteria in subgingival
plaque from the deepest pockets and in saliva
Quantitative analysis of the total bacterial count and
periodontopathic bacterial counts, including P. gingivalis,
P. intermedia, and A. actinomycetemcomitans, was per-
formed using a modification of the Invader PLUS assay
[7, 22, 28, 29]. Briefly, bacterial DNA was extracted
from samples of the subgingival plaque from the dee-
pest pockets by suspending each plaque sample in 1
mL of phosphate-buffered saline, pH 7.4 and processing
using the MagNA Pure LC Total Nucleic Acid Isolation
Kit (Roche, Basel, Switzerland) according to the manu-
facturer’s instructions. Similarly, bacterial DNA was ex-
tracted from the 100-μl whole saliva samples using the
MagNA Pure LC Total Nucleic Acid Isolation Kit. The
individual sequences of each bacterial species were
obtained from a public database (National Center for
Biotechnology Information, Bethesda, MD). Primers for
each species were designed based on a region of the
16S rRNA gene. A pair of universal primers and a uni-
versal probe were used to determine the total number
of bacteria. Primary probes and Invader oligos were de-
signed using the Invader technology creator (HOLO-
GIC, Madison, WI) and were based on sequences in the
amplified regions [7, 28–30].
Template DNA was added to a 15-μL reaction mixture
containing primers for each species, 50 μM dNTPs,
700 nM primary probe, 70 nM Invader oligo, 2.5 U
polymerase chain reaction (PCR) enzyme (EagleTaq
DNA polymerase, Roche, Basel, Switzerland), and the
Invader core reagent kit (Cleavase XI Invader core reagent
kit, HOLOGIC, Madison, WI) containing a fluorescence
resonance energy transfer (FRET) mix and an enzyme/
MgCl2 solution. The reaction mixture was preheated at
95 °C for 20 min, and a 2-step PCR reaction (95 °C for
1 s and 63 °C for 1 min) was performed for 35 cycles
using an ABI PRISM 7900 thermocycler (Applied
Biosystems, Foster City, CA). Fluorescence values of
carboxyfluorescein (FAM; wavelength/bandwidth: excita-
tion, 485/20 nm; emission, 530/25 nm) were measured at
the end of the incubation/extension step at 63 °C for
each cycle.
The limit of detection for this method was determined
for each species with dilutions of bacterial DNA. Standard
curves were constructed based on a crossing point deter-
mined by the fit point method.
Next, the proportions of the 3 pathogens within the
total bacterial counts were determined [10, 31]. Bacterial
ratios (%) and bacterial counts (log10) for each species also
were used in various comparison and diagnostic analyses.
Measurement of IgG titers against periodontal bacteria
Serum IgG antibody titers against periodontal pathogens
were determined by Leisure Inc. using enzyme-linked
immunosorbent assay (ELISA) [32]. The method and
selection of bacterial antigens were based on previous
reports [7, 24–27]. Briefly, sonicated preparations of P.
gingivalis FDC381, P. intermedia ATCC25611, and A.
actinomycetemcomitans ATCC29523 were used as repre-
sentative bacterial antigens. Each antigen was diluted to
10 μg/mL with 0.1 M carbonate buffer (pH 9.6). An ali-
quot of this diluted solution (100 μL) then was added to
each well in a flat-bottomed microtiter plate (Greiner
Co. Ltd., Frickenhausen, Germany) and the plate was
stored overnight at 4 °C. Each well with immobilized
antigen was washed three times with PBS containing
0.05% Tween-20 (PBST). Subsequently, a diluted serum
sample (3100-fold dilution with PBST) was added to
each well. After incubation at 37 °C for 2 h, each well
was washed three times with PBST and bound/free (B/F)
separation was carried out. Next, a 100-μl aliquot of
1:5000 diluted alkaline phosphatase-conjugated goat
antihuman IgG antibody (Jackson Immuno Research
Laboratories, Inc., Baltimore, MD) was added to each
well. After incubation at 37 °C for 2 h, each well was
washed three times with PBST and B/F separation was
carried out. Thereafter, 50 μl of p-nitrophenyl phosphate
(Wako Pure Chemical Industries, Ltd., Osaka, Japan)
adjusted to 1 mg/ml with 10% diethanolamine buffer
(pH 9.8) was added to each well as substrate. The plate
then was incubated at room temperature for 10–20 min.
The enzymatic reaction was terminated by adding
50 μl of 3 M NaOH, and optical density (measurement
at 405 nm; reference at 490 nm) was measured in a
Micro ELISA Auto Reader (Bio-Rad Laboratories,
Hercules, CA).
The standard titration curves were formulated using
serial dilutions of pooled control serum collected from
participants without periodontitis. The absorbance of
each sample after reaction was defined as an ELISA unit
(EU), such that 100 EU corresponded to 1:3200 dilution of
the control sample. The antibody titers were expressed as
standardized values calculated as follows: (EU for study
serum samples—EU for control samples)/2 standard
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deviations (SD), using SDs as determined based on ELISA
of the control samples [25].
Statistical analysis
Descriptive analysis of the collected data was per-
formed; the results are presented as medians. The
Mann Whitney U test was used to compare clinical pa-
rameters, periodontal bacterial amounts, and IgG titers
with or without progression of chronic periodontitis
(CP). Only correlation with sex was performed using
the Fisher’s exact test. To determine an optimal test for
distinguishing follow-up patients with periodontal pro-
gression or stability, we constructed receiver operating
characteristic (ROC) curves and set the cutoff point
based on the minimum difference between sensitivity
and specificity [6, 25]. On the basis of the calculated cutoff
point, we then made appropriate cross-tabulations. Diag-
nostic values were calculated by the Fisher’s exact test to
identify statistically significant differences. To check the
correlation of periodontal bacteria with disease progres-
sion, logistic regression analysis was carried out to
eliminate possible confounding variables. This study
was originally designed to evaluate the diagnostic salivary
levels of P. gingivalis in patients with or without the
progression of CP. Calculation of the sample size was de-
scribed in our previous report [7]. For the present study,
post-hoc power analysis calculation using the cross table
for patients with or without progression of CP against
positive or negative for P. gingivalis suggested that groups
would have to consist of at least 41 subjects each. A
similar analysis revealed that groups of at least 26 sub-
jects each would be required to detect differences in P.
gingivalis counts (log10) in subgingival plaque from the
deepest pockets. All analyses were performed by inde-
pendent statisticians (Y.N., E.K., and N.H.) using IBM
SPSS Statistics ver. 19.0 software (IBM Japan, Tokyo,
Japan) and S-plus (ver. 6.0, NTT DATA, Tokyo, Japan).
Results
Of the 163 follow-up patients enrolled in the study, 32
dropped out during the study period due to a variety of
causes (including occurrence of the Great East Japan
Earthquake), and 7 others withdrew because of the use
during the study of antimicrobial agents for the treat-
ment of acute periodontal abscesses. In the end, 124
subjects successfully completed the study protocol. Of
the 124 patients who completed the study protocol, 62
follow-up patients (50%) presented with disease progres-
sion, whereas the same number of patients (50%) demon-
strated stable disease.
Demographic characteristics and biological variables of
the study participants at baseline are shown in Table 1.
Table 1 Clinical parameters and bacterial levels at baseline in the patients with stable CP and progressive CP
Stable CP patients (n = 62) Progressive CP patients (n = 62) p-value
Gender (male/female) 23/39 26/36 0.199
Age (year) 60.0 (56.0–66.0) 61 (52.5–68.0) 0.193
Smoking (non-smoker/smoker) 59/3 61/1 0.619
PlI 0.12 (0.06–0.30) 0.17 (0.07–0.45) 0.291
BOP (% positive) 3.62 (1.53–11.28) 6.54 (2.48–10.45) 0.022*
PPD (mm) 2.15 (1.80–2.53) 2.26 (1.76–2.57) 0.885
The deepest PPD (mm) 4.0 (4.00–6.00) 5.0 (4.25–7.75) <0.001*
CAL (mm) 2.8 (2.34–3.33) 2.87 (2.78–3.62) 0.710
The deepest CAL (mm) 7.00 (5.25–8.00) 7.5 (6.25–9.00) 0.042*
P. gingivalis counts (log10) Subgingival plaque 1.00 (1.00–3.17) 1.64 (1.00–4.29) <0.001*
P. gingivalis counts (log10) Saliva 2.59 (1.00–3.66) 3.34 (2.67–4.08) 0.002*
P. gingivalis IgG titers (EU) 1.28 (0.32–4.26) 1.63 (0.95–6.34) 0.503
P. intermedia counts (log10) Subgingival plaque 1.00 (1.00–1.63) 1.00 (1.00–2.72) 0.049*
P. intermedia counts (log10) Saliva 1.87 (1.00–3.65) 3.02 (1.41–4.05) 0.038*
P. intermedia IgG titers (EU) −0.39 (0.47–0.13) −0.27 (0.45–0.21) 0.173
A. actinomycetemcomitans counts (log10) Subgingival plaque 1.00 (1.00–1.00) 1.00 (1.00–1.00) 0.164
A. actinomycetemcomitans counts (log10) Saliva 1.00 (1.00–1.00) 1.00 (1.00–1.50) 0.065
A. actinomycetemcomitans IgG titers (EU) −0.26 (0.41–0.03) −0.30 (0.40–0.10) 0.278
Value represent median value (25–75 percentile). CP chronic periodontitis, PlI plaque index, BOP bleeding on probing, PPD probing pocket depth, CAL clinical
attachment level, EU enzyme-linked immunosorbent assay unit
The deepest PPD and the deepest CAL indicate the value of the sites which is the deepest PPD and the deepest CAL in each subject, respectively. p values for
gender were calculated using the Fisher’s exact test, and all others were Mann Whitneys’ U tests. The *mark represent statistical significance between stable CP
patients and progressive CP patients (p < 0.05)
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BOP, the deepest PPD, and the deepest CAL were
significantly higher in subjects who exhibited progressive
CP compared to patients with stable CP. For the patho-
gens, P. gingivalis counts in subgingival plaque from the
deepest pockets, P. intermedia counts in subgingival
plaque from the deepest pockets, P. gingivalis counts in
saliva, and P. intermedia counts in saliva were significantly
higher in subjects who exhibited progressive CP compared
to patients with stable CP.
Figure 1 shows the scatter plots of periodontal pathogen
counts in saliva compared to those in subgingival plaque
from the deepest pockets. Correlation coefficients of bac-
terial counts from saliva and subgingival plaque from the
deepest pockets were 0.540 (p < 0.001) for P. gingivalis,
0.484 (p < 0.001) for P. intermedia, and 0.399 (p < 0.001)
for A. actinomycetemcomitans. However, in some samples
of subgingival plaque from the deepest pockets, bacterial
counts were below the limit of detection. Notably, A. acti-
nomycetemcomitans was not detected in 95.7% of samples
of subgingival plaque from the deepest pockets.
To determine an optimal test for distinguishing follow-
up patients with periodontal progression from those with
stable CP, we constructed receiver operating characteristic
curves and set the cutoff points on the basis of the
minimum differences between sensitivity and specificity
[6, 25]. Furthermore, on the basis of the cutoff point,
we made appropriate cross-tabulations.
Table 2 shows the cutoff points, sensitivity, specificity,
positive predictive value, negative predictive value, likeli-
hood, and area under the curve for the periodontal bac-
terial counts and IgG titers. Among the 3 periodontal
pathogens, only P. gingivalis yielded counts that demon-
strated significant correlation with CP status (cutoff
point = 1.370 (p < 0.001), sensitivity = 0.548, specificity =
0.774, positive predictive value = 0.708, negative predictive
value = 0.632, likelihood ratio = 2.429, AUC = 0.666).
The area under the curve of the P. gingivalis counts
was the largest amongst all markers evaluated. The spe-
cificity of P. gingivalis counts in subgingival plaque
from the deepest pockets was higher than that for salivary
P. gingivalis counts (0.323) [7].
To check the importance of periodontal bacteria in
the progression of periodontal disease, logistic regression
analysis was carried out to eliminate possible confounding
variables. As shown in Table 3, the crude odds ratio of the
deepest CAL in each subject, and P. gingivalis count were
statistically significant. According to the multivariate ad-
justed odds ratio, only P. gingivalis counts exhibited a
significant (p = 0.034) correlation with CP status.
Discussion
In this study, we evaluated potential markers for periodon-
titis progression during a 24-month study interval. The
results suggested associations between periodontitis pro-
gression and bacterial levels in subgingival plaque recovered
from the deepest pockets. We previously used PCR to
examine the presence of each of six species of periodonto-
pathic bacteria in whole saliva and subgingival plaque [33].
A statistical relationship was found between the presence
of P. gingivalis, P. intermedia, Prevotella nigrescens, and T.
denticola in saliva and in periodontal pocket samples; in
Fig. 1 Scatter plots of periodontal pathogen counts from salivary
and subgingival plaque from the deepest pockets for individual
subjects. Correlations of periodontal pathogen counts in saliva and
subgingival plaque from the deepest pockets were statistically
significant. The correlation coefficient of bacterial counts in saliva
and subgingival plaque from the deepest pockets was the highest
for P. gingivalis (panel a) when compared with other pathogens
(panel b, c). Note, for each of the three bacterial species, that
bacterial counts were below the limit of detection in some
subgingival plaque samples; this observation was most notable
for A. actinomycetemcomitans, which could not be detected
in >95% of samples (panel c).
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the event of disagreement, the organisms were more
frequently present in saliva than in periodontal pockets
(p <0.001). Meanwhile, A. actinomycetemcomitans and
T. forsythia were not reliably detected by sampling of
either saliva or periodontal pockets [31].
Our results indicated that The P. gingivalis counts of
subgingival plaque from the deepest pockets might be
used as indicators of the progression of periodontitis.
The results of the present study, along with those of our
previous study [7], suggest the value of P. gingivalis in
assessing the progression of CP. Specificity of P. gingivalis
counts in subgingival plaque from the deepest pockets
was higher than that in saliva. The absolute pathogen bur-
den is clearly more informative than merely a dichotomi-
zation between carriers and noncarriers [34]. P. gingivalis,
alone or in combination with T. forsythia and T. denticola,
has been reported to exhibit the deepest mean pocket
depths [9]. The thresholds predictive of progressive peri-
odontitis correspond to 0.01% for A. actinomycetemcomi-
tans, 0.1% for P. gingivalis, and 2.5% for P. intermedia
[13]. In an 18-month-long study, the presence of P.
gingivalis and P. intermedia in subgingival plaque at
proportions exceeding 2% was a significant predictor of
periodontitis progression in older adults [35]. These re-
sults support the appropriateness using P. gingivalis as a
marker for the progression of CP, and are consistent with
the results obtained in the present study. In the work de-
scribed here, we evaluated the diagnostic value for peri-
odontal disease of the levels of bacteria in subgingival
plaque from the deepest pockets (Table 2), in extension of
our previous report [7] showing the diagnostic value for
periodontal disease of salivary bacterial levels. Specificity,
positive predictive value, likelihood ratio, and AUC of P.
gingivalis counts for the progression of periodontal disease
Table 2 Diagnostic values of subgingival plaque bacterial levels and serum IgG titers for periodontal bacteria





P. gingivalis counts (log10) 1.370 <0.001 0.548 0.774 0.708 0.632 2.429 0.666
P. intermedia counts (log10) 1.040 0.077 0.371 0.774 0.622 0.552 1.643 0.568
A. actinomycetemcomitans
counts (log10)
1.151 0.171 0.065 0.984 0.800 0.513 4.000 0.478
P. gingivalis IgG titera 1.355 >0.999 0.516 0.500 0.508 0.508 1.032 0.444
P. intermedia IgG titera −0.345 0.281 0.565 0.548 0.556 0.557 1.250 0.535
A. actinomycetemcomitans
IgG titera
−0.275 0.590 0.452 0.484 0.467 0.469 0.875 0.571
Fisher’s exact test was used for statistical analysis (p < 0.05). The P. gingivalis counts was statistically significant
The area under the curve of the P. gingivalis counts was the largest amongst all markers. Subgingival plaque P. gingivalis counts specificity was higher than
salivary P. gingivalis counts (0.323) [7]
EU enzyme-linked immunosorbent assay unit, AUC area under the curve
a: J Periodontal Res. 2016 Dec;51(6):768–778
Table 3 Multiple logistic regression analysis for progression of chronic periodontitis
Crude OR (95% CI) p-value Multivariate adjusted OR (95% CI) p-value
Gender (male/female) 0.62 (0.30–1.29) 0.200 1.06 (0.43–2.65) 0.893
Age (years) 1.02 (0.98–1.07) 0.271 1.03 (0.97–1.08) 0.324
PlI 2.15 (0.37–12.48) 0.393 0.88 (0.10–8.10) 0.909
BOP (% positive) 1.04 (1.00–1.08) 0.077 1.03 (0.98–1.08) 0.285
CAL (mm) 1.14 (0.69–1.87) 0.603 0.72 (0.33–1.58) 0.415
The deepest CAL (mm) 1.25 (1.01–1.54) 0.039* 1.35 (0.99–1.85) 0.059
P. gingivalis counts (log10) 4.163 (1.913–9.06) <0.001* 1.56 (1.03–2.34) 0.034*
P. gingivalisIgG titers (EU) 1.01 (0.98–1.05) 0.422 1.01 (0.99–1.03) 0.276
P. intermedia counts (log10) 2.022 (0.92–4.443) 0.080 0.99 (0.52–1.76) 0.973
P. intermedia IgG titers (EU) 1.45 (0.46–4.60) 0.531 2.04 (0.50–8.22) 0.318
A. actinomycetemcomitans counts (log10) 4.207 (0.457–38.757) 0.205 44.70 (0.05–36,574) 0.267
A. actinomycetemcomitans IgG titers (EU) 0.78 (0.33–1.85) 0.581 0.52 (0.15–1.76) 0.291
The crude odds ratio of the deepest CAL in each subject, P. gingivalis count, and the combination of P. gingivalis counts and P. gingivalis IgG titers were
statistically significant. According to the multivariate adjusted odds ratio, only P. gingivalis counts was statistically significant (p = 0.034)
OR odds ratio, 95% CI confidence interval with 95% significance level, PlI plaque index, BOP bleeding on probing, CAL clinical attachment level;Counts, each
bacteria counts in subgingival plaque, EU enzyme-linked immunosorbent assay unit
*p < 0.05
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in subgingival plaque were higher than the respective
parameters for bacterial counts in saliva. However, we
note that bacterial counts could not be determined in
numerous samples of subgingival plaque from the dee-
pest pockets, with detection failing for P. gingivalis, P.
intermedia, and A. actinomycetemcomitans in 59.7,
70.2, and 95.7% of samples, respectively.
Subgingival plaque samples from the deepest pockets
did not yield detectable levels of periodontal bacteria in
several individuals enrolled in this study; however, the sali-
vary samples were able to detect periodontal bacteria in
these cases. An inherent limitation of sampling subgingival
plaque from the deepest pockets is that these specimens
only reflect the condition of sampling site. Notably, how-
ever, P. gingivalis counts in subgingival plaque from the
deepest pockets yielded greater sensitivity and specificity
for periodontal progression than did P. gingivalis counts
in saliva. In this context, it is worth noting that sampling
of subgingival plaque from the deepest pockets is more
difficult than sampling of saliva. Clinicians using these
tests should consider these merits and demerits when con-
sidering the use of sampling for periodontal bacteria in
subgingival plaque from the deepest pockets. Further in-
vestigations will be needed to assess the utility of salivary
bacteria levels as markers of periodontal condition.
Conclusions
The P. gingivalis counts of subgingival plaque from the
deepest pockets may be associated with the progression
of periodontitis.
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